Related Experiment Videos
Degradable dU-based DNA template as a standard in real-time PCR quantitation
J L Pennings1, L T Van De Locht, J H Jansen
1Central Hematology Laboratory, University Medical Center St Radboud Nijmegen, Nijmegen, The Netherlands.
Leukemia
|December 26, 2001
Summary
This study introduces dU-DNA as a novel positive control for real-time quantitative PCR (qPCR) assays. This method offers decontamination and precise molecular quantification, improving diagnostic accuracy for rare genetic targets.
Area of Science:
- Molecular Biology
- Biotechnology
- Diagnostic Assays
Background:
- Real-time quantitative PCR (qPCR) assays require reliable positive controls.
- Clinical qPCR assays face challenges with rare molecular aberrations and limited patient material.
- Cloned DNA poses contamination risks, making it an undesirable control option.
Purpose of the Study:
- To describe the use of deoxyuridine (dU)-containing DNA (dU-DNA) as a positive control template in real-time quantitative PCR.
- To demonstrate the decontamination capability of dU-DNA using uracil N-glycosylase (UNG).
- To establish dU-DNA for accurate quantification in terms of molecule numbers.
Main Methods:
- Development and application of dU-DNA constructs as positive control templates.
- Incorporation of uracil N-glycosylase (UNG) for decontamination of reaction mixtures.
- Spectroscopic quantification of synthetic dU-DNA constructs for accurate control.
- Application of the method for detecting the E2A-Pbx1 gene fusion.
Main Results:
- dU-DNA constructs can be effectively decontaminated using UNG in qPCR reactions.
- UNG-containing reactions maintain diagnostic sensitivity.
- UNG-negative reactions are suitable for positive and quantitative controls.
- Spectroscopically quantified synthetic dU-DNA provides more accurate controls than cell line units.
Conclusions:
- dU-DNA serves as a novel, easily integrated control template for existing PCR protocols.
- The dU-DNA method enhances accuracy and safety in real-time quantitative PCR.
- This approach facilitates reliable diagnostics for rare genetic targets in clinical applications.